Why the study?
Does calcium-channel blocker therapy prevent adverse cardiovascular events compared to beta-blockers in East Asian patients after AMI with preserved LVEF?
Does calcium-channel blocker therapy prevent adverse cardiovascular events compared to beta-blockers in East Asian patients after AMI with preserved LVEF?
Calcium-channel blockers may serve as a safe alternative to beta-blockers for secondary prevention in East Asian patients with preserved LVEF following an acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
May support CCB as beta-blocker alternative post-AMI with preserved LVEF; hypothesis-generating and requires RCT confirmation in East Asians.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: